RedHill Biopharma Raises $8 Million and Forges Ahead with Promising Pipeline
In a recent announcement, RedHill Biopharma Ltd (NASDAQ: RDHL), a leading specialty biopharmaceutical company, confirmed the successful completion of its registered direct offering. The $8 million fundraise is expected...
Jan 26, 2024
• Major Pharmaceutical Preparations Industry
Stock Offering
NASDAQ